FDA Approves Samsca For The Treatment Of Hyponatremia

May 24, 2009

The FDA (Food and Drug Administration) has approved Samsca (tolvaptan), in tablet form, for the treatment of hyponatremia. Hyponatremia is when levels of sodium in the blood are abnormally low – it is associated with dehydration.

Norman Stockbridge, M.D., Director, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, FDA, said “With the approval of Samsca, physicians will have an additional tool to treat hyponatremia.”
Read the rest of this entry »

Advertisements

Yolo County, Calif., Approves Proposal To Cut Funding For Health Care Services To Undocumented Immigrants

May 23, 2009

Yolo County, Calif., Board of Supervisors on Tuesday approved a proposal to cut county funding for health care services for undocumented immigrants in an effort to save the county more than $1 million, the Sacramento Bee reports (Sangree, Sacramento Bee, 5/20).

California counties have been taking such action amid the economic recession to reduce their budgets. In February, Sacramento County voted to prohibit undocumented immigrants from receiving care at county clinics to save an estimated $2.4 million. Contra Costa County last month cut services for undocumented adults, seeking to save an estimated $6 million. Yolo County is facing a $24 million budget deficit for fiscal year 2009-2010 (Kaiser Health Disparities Report, 5/7).
Read the rest of this entry »


Yolo County, Calif., Approves Proposal To Cut Funding For Health Care Services To Undocumented Immigrants

May 23, 2009

Yolo County, Calif., Board of Supervisors on Tuesday approved a proposal to cut county funding for health care services for undocumented immigrants in an effort to save the county more than $1 million, the Sacramento Bee reports (Sangree, Sacramento Bee, 5/20).

California counties have been taking such action amid the economic recession to reduce their budgets. In February, Sacramento County voted to prohibit undocumented immigrants from receiving care at county clinics to save an estimated $2.4 million. Contra Costa County last month cut services for undocumented adults, seeking to save an estimated $6 million. Yolo County is facing a $24 million budget deficit for fiscal year 2009-2010 (Kaiser Health Disparities Report, 5/7).
Read the rest of this entry »


Oregon House Approves Bill Mandating Insurance Coverage Of HPV Vaccine

April 22, 2009

The Oregon House on Wednesday voted 48-12 to pass a bill (H.B. 2794) that would require state-regulated insurance plans to cover the cost of the human papillomavirus vaccine for girls and women, the Oregonian reports. The vaccine, which FDA approved in 2006 for girls and young women ages nine to 26, protects against certain strains of HPV that cause cervical cancer. The bill does not require that people receive the vaccine, and its coverage requirements do not apply to “large companies that are self-insured.”
Read the rest of this entry »


Okla. Senate Approves Bill Requiring Reporting Of Detailed Data On Women Seeking Abortions

April 21, 2009

The Oklahoma Senate on Wednesday passed the Statistical Reporting on Abortion Act (H.B. 1595) that would require doctors performing abortions to provide the Oklahoma State Department of Health with detailed information about women seeking the procedure, including their age, race, marital status, number of previous pregnancies and reasons for seeking an abortion, the AP/Oklahoman reports. The bill, sponsored by state Sen. Todd Lamb (R), passed by a vote of 34-10, with with all “no” votes cast by Democrats. It would require abortion providers to gather information from “37 sections of questions,” which the health department would use to produce an annual report. The bill also would prohibit abortions based on the sex of the fetus.
Read the rest of this entry »


FDA Approves Orphan Drug ATryn To Treat Rare Clotting Disorder

February 12, 2009

The U.S. Food and Drug Administration issued its first approval for a biological product produced by genetically engineered (GE) animals.

The approval is for ATryn, an anticoagulant used for the prevention of blood clots in patients with a rare disease known as hereditary antithrombin (AT) deficiency. These patients are at high risk of blood clots during medical interventions, such as surgery, and before, during and after childbirth.
Read the rest of this entry »


FDA Approves Boston Scientific’s Express(R) SD Renal Stent System

January 16, 2009

Boston Scientific Corporation (NYSE: BSX) announced that the U.S. Food and Drug Administration (FDA) has approved the Express(R) SD Renal Monorail(R) Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries. The Express SD System is the first low-profile, pre-mounted stent approved for use in renal arteries in the United States. It is the only FDA-approved renal stent designed to provide additional proximal end support.
Read the rest of this entry »